AFDX-384

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

AFDX-384 (BIBN-161) is a drug which acts as a selective antagonist of the muscarinic acetylcholine receptors, with selectivity for the M 2 and M 4 subtypes. It is used mainly for mapping the distribution of M 2 and M 4 muscarinic receptors in the brain, and studying their involvement in the development and treatment of dementia and schizophrenia.

AFDX-384 (BIBN-161) is a drug which acts as a selective antagonist of the muscarinic acetylcholine receptors, with selectivity for the M 2 and M 4 subtypes. It is used mainly for mapping the distribution of M 2 and M 4 muscarinic receptors in the brain, and studying their involvement in the development and treatment of dementia and schizophrenia.

See also

Pirenzepine (M 1 selective antagonist)

Text derived from https://en.wikipedia.org/w/index.php?oldid=1329183857 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.